Platform forecasts COVID-19 trial outcomes
The technology from Opyl uses artificial intelligence to anticipate a COVID-19 treatment, vaccine, diagnostic or device’s chances of success in a study.
Archives for September 15, 2020
Medidata shifts its Commercial Data Solutions unit
Acquired in 2018, the data analytics provider formerly known as Shyft Analytics will now be part of the company’s Acorn by AI unit.
AstraZeneca unveils Phase III kidney treatment results
In a Phase III trial, Farxiga reportedly showed reduction in the risk of kidney failure, and cardiovascular (CV) or renal death, in CKD patients.